We report three principal findings: (1) patients with GAD exhibited significantly elevated baseline serum OT levels compared to healthy controls, a difference driven primarily by female patients;(2) OT levels were positively correlated with baseline anxiety severity; and (3) the OXTR rs2254298 genotype was associated with differential treatment response at week 8. This evidence concerns the gene OXTR and Anxiety.